Shenzhen Mindray Bio-Medical Electronics Co Ltd is a developer, manufacturer, and supplier of medical devices. The company is focused on the medical industry in the fields of Patient Monitoring & Life Support, InVitro Diagnostics, and Medical Imaging.
1999
n/a
LTM Revenue $5.4B
LTM EBITDA $2.0B
$33.9B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Mindray has a last 12-month revenue (LTM) of $5.4B and a last 12-month EBITDA of $2.0B.
In the most recent fiscal year, Mindray achieved revenue of $5.1B and an EBITDA of $2.0B.
Mindray expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Mindray valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $5.4B | XXX | $5.1B | XXX | XXX | XXX |
Gross Profit | $3.4B | XXX | $3.2B | XXX | XXX | XXX |
Gross Margin | 63% | XXX | 63% | XXX | XXX | XXX |
EBITDA | $2.0B | XXX | $2.0B | XXX | XXX | XXX |
EBITDA Margin | 37% | XXX | 39% | XXX | XXX | XXX |
EBIT | $1.9B | XXX | $1.8B | XXX | XXX | XXX |
EBIT Margin | 35% | XXX | 36% | XXX | XXX | XXX |
Net Profit | $1.7B | XXX | $1.6B | XXX | XXX | XXX |
Net Margin | 32% | XXX | 32% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 17, 2025, Mindray's stock price is CNY 215 (or $30).
Mindray has current market cap of CNY 260B (or $36.3B), and EV of CNY 243B (or $33.9B).
See Mindray trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$33.9B | $36.3B | XXX | XXX | XXX | XXX | $1.40 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 17, 2025, Mindray has market cap of $36.3B and EV of $33.9B.
Mindray's trades at 6.6x EV/Revenue multiple, and 16.8x EV/EBITDA.
Equity research analysts estimate Mindray's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Mindray has a P/E ratio of 21.4x.
See valuation multiples for Mindray and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $36.3B | XXX | $36.3B | XXX | XXX | XXX |
EV (current) | $33.9B | XXX | $33.9B | XXX | XXX | XXX |
EV/Revenue | 6.3x | XXX | 6.6x | XXX | XXX | XXX |
EV/EBITDA | 17.1x | XXX | 16.8x | XXX | XXX | XXX |
EV/EBIT | 18.2x | XXX | 18.6x | XXX | XXX | XXX |
EV/Gross Profit | 10.0x | XXX | n/a | XXX | XXX | XXX |
P/E | 21.4x | XXX | 22.3x | XXX | XXX | XXX |
EV/FCF | 23.2x | XXX | 23.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMindray's last 12 month revenue growth is 11%
Mindray's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Mindray's rule of 40 is 51% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mindray's rule of X is 65% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Mindray and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 11% | XXX | 11% | XXX | XXX | XXX |
EBITDA Margin | 37% | XXX | 39% | XXX | XXX | XXX |
EBITDA Growth | 12% | XXX | 3% | XXX | XXX | XXX |
Rule of 40 | 51% | XXX | 51% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 65% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | 10% | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 28% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mindray acquired XXX companies to date.
Last acquisition by Mindray was XXXXXXXX, XXXXX XXXXX XXXXXX . Mindray acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Mindray founded? | Mindray was founded in 1999. |
Where is Mindray headquartered? | Mindray is headquartered in China. |
Is Mindray publicy listed? | Yes, Mindray is a public company listed on SHE. |
What is the stock symbol of Mindray? | Mindray trades under 300760 ticker. |
When did Mindray go public? | Mindray went public in 2018. |
Who are competitors of Mindray? | Similar companies to Mindray include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Mindray? | Mindray's current market cap is $36.3B |
What is the current revenue of Mindray? | Mindray's last 12 months revenue is $5.4B. |
What is the current revenue growth of Mindray? | Mindray revenue growth (NTM/LTM) is 11%. |
What is the current EV/Revenue multiple of Mindray? | Current revenue multiple of Mindray is 6.3x. |
Is Mindray profitable? | Yes, Mindray is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Mindray? | Mindray's last 12 months EBITDA is $2.0B. |
What is Mindray's EBITDA margin? | Mindray's last 12 months EBITDA margin is 37%. |
What is the current EV/EBITDA multiple of Mindray? | Current EBITDA multiple of Mindray is 17.1x. |
What is the current FCF of Mindray? | Mindray's last 12 months FCF is $1.5B. |
What is Mindray's FCF margin? | Mindray's last 12 months FCF margin is 27%. |
What is the current EV/FCF multiple of Mindray? | Current FCF multiple of Mindray is 23.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.